Laddar...
Environmental Risk Assessment of Clinical Trials Involving Modified Vaccinia Virus Ankara (MVA)-Based Vectors
The modified vaccinia virus Ankara (MVA) strain, which has been developed as a vaccine against smallpox, is since the nineties widely tested in clinical trials as recombinant vector for vaccination or gene therapy applications. Although MVA is renowned for its safety, several biosafety aspects need...
Sparad:
| Huvudupphovsmän: | , , , |
|---|---|
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Bentham Science Publishers
2013
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4031919/ https://ncbi.nlm.nih.gov/pubmed/24397528 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2174/156652321306140103221941 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|